Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Mahoko Furujo"'
Autor:
Asami Ukida, Yasuo Nakahara, Mahoko Furujo, Chika Takada, Kosuke Hitomi, Wataru Mukai, Yusuke Takahashi, Takafumi Goto, Koji Aoyama
Publikováno v:
Journal of Pediatric Surgery Case Reports, Vol 101, Iss , Pp 102766- (2024)
Introduction: The most prevalent cause of virilization in newborns is congenital adrenal hyperplasia. A very infrequent cause, on the other hand, is a virilizing maternal adrenal tumor. We present two 46XX siblings with virilization of the external g
Externí odkaz:
https://doaj.org/article/bf00786dd7624af382792f5cdf30d068
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 13, Iss C, Pp 69-75 (2017)
Early initiation of enzyme replacement therapy (ERT) has demonstrated clinical benefit in patients with mucopolysaccharidosis type VI (MPS VI), a progressive, multisystem autosomal recessive lysosomal disorder caused by N-acetylgalactosamine-4-sulpha
Externí odkaz:
https://doaj.org/article/f8e6e45c385946bfaa4e34ef15cca514
Autor:
Yoshiaki Takahashi, Yasuhiro Manabe, Yumiko Nakano, Taijun Yunoki, Syoichiro Kono, Hisashi Narai, Mahoko Furujo, Koji Abe
Publikováno v:
Case Reports in Neurology, Vol 9, Iss 1, Pp 17-21 (2017)
We report a 16-year-old man with disorders of tetrahydrobiopterin metabolism due to dihydropteridine reductase (DHPR) deficiency. He revealed moderate mental retardation, parkinsonism, and spastic paralysis with levodopa and 5-hydroxytryptophan (5-HT
Externí odkaz:
https://doaj.org/article/f0c6d8276b084be4978dda12b9472a5e
Autor:
Mika Suga, Takayuki Kondo, Keiko Imamura, Ran Shibukawa, Yasue Okanishi, Yukako Sagara, Kayoko Tsukita, Takako Enami, Mahoko Furujo, Kaoru Saijo, Yukio Nakamura, Mitsujiro Osawa, Megumu K. Saito, Shinya Yamanaka, Haruhisa Inoue
Publikováno v:
Stem Cell Research, Vol 36, Iss , Pp - (2019)
Mucopolysaccharidosis type I (MPS I) is a rare inherited metabolic disorder caused by defects in alpha-L-iduronidase (IDUA), a lysosomal protein encoded by IDUA gene. MPS I is a progressive multisystemic disorder with a wide range of symptoms, includ
Externí odkaz:
https://doaj.org/article/b0a8c2006a5343dbb64ae839541f07d0
Publikováno v:
Epilepsy and Behavior Case Reports, Vol 2, Iss C, Pp 37-39 (2014)
We assessed the clinical characteristics and efficacy of neurotransmitters and levetiracetam in a patient with hyperphenylalaninemia due to dihydropteridine reductase (DHPR) deficiency who developed epileptic seizures. A boy with DHPR deficiency, who
Externí odkaz:
https://doaj.org/article/d6449756a5fa4cfe8fd598ad0f6befb7
Autor:
Mahoko Furujo, Motoharu Ochi, Yousuke Higuchi, Takahiro Namba, Yuki Ebuchi, Hiroki Tsuchiya, Shoko Fujinaga, Naoko Urata, Toshihide Kubo, Michiko Kishi, Narumi Hara
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 33:1417-1423
Background The relationship between growth hormone (GH)-replacement therapy and the thyroid axis in GH-deficient (GHD) children remains controversial. Furthermore, there have been few reports regarding non-GHD children. We aimed to determine the effe
Autor:
Shintaro Fujiwara, Yousuke Higuchi, Yuki Ebuchi, Yu Fukushima, Takahiro Ohkura, Mahoko Furujo
Publikováno v:
Journal of Paediatrics and Child Health. 59:590-591
Publikováno v:
Clinical Rheumatology
Autor:
Toru Fukuhara, Mahoko Furujo, Hiroyuki Tanaka, Mizuho Aoi, Yusuke S. Hori, Takushi Inoue, Michiari Umakoshi, Kazunori Oda, Masato Ishi, Takahiro Ohkura, Yuki Ebisudani
Publikováno v:
Pediatric Neurosurgery. 53:167-170
Turner syndrome is a chromosomal disorder usually caused by complete deletion of an X chromosome, with deletion in the short arm of the X chromosome being a rare cause of the condition. Patients with Turner syndrome commonly develop hypertension, and
Autor:
Syoichiro Kono, Hisashi Narai, Yumiko Nakano, Mahoko Furujo, Yoshiaki Takahashi, Koji Abe, Taijun Yunoki, Yasuhiro Manabe
Publikováno v:
Case Reports in Neurology, Vol 9, Iss 1, Pp 17-21 (2017)
Case Reports in Neurology
Case Reports in Neurology
We report a 16-year-old man with disorders of tetrahydrobiopterin metabolism due to dihydropteridine reductase (DHPR) deficiency. He revealed moderate mental retardation, parkinsonism, and spastic paralysis with levodopa and 5-hydroxytryptophan (5-HT